Skip to main content
Clinical Trials/DRKS00025254
DRKS00025254
Recruiting
Not Applicable

Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccination - COV-PEDONK

Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität0 sites100 target enrollmentMay 26, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eed for vaccination against COVID-19
Sponsor
Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität

Eligibility Criteria

Inclusion Criteria

  • Patients treated for malignoima (both during intensive chemotherapy and in maintenance therapy) up to 3 months after cessation of chemotherapy
  • \- Age 16\-18 years (youngert once the vaccine will be approved for this age Group)
  • \- No contraindication for SARS\-CoV\-2 vaccination
  • \- Written informed consent Patient and caregiver

Exclusion Criteria

  • \- known inborn immunodeficiency
  • \- Prior infection with SARS\-CoV\-2

Outcomes

Primary Outcomes

Not specified

Similar Trials